GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (CHIX:ORPHAc) » Definitions » Days Inventory

Orphazyme AS (CHIX:ORPHAC) Days Inventory : 0.00 (As of Jun. 2022)


View and export this data going back to 2021. Start your Free Trial

What is Orphazyme AS Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Orphazyme AS's Average Total Inventories for the six months ended in Jun. 2022 was kr0.00 Mil. Orphazyme AS's Cost of Goods Sold for the six months ended in Jun. 2022 was kr0.00 Mil.

The historical rank and industry rank for Orphazyme AS's Days Inventory or its related term are showing as below:

CHIX:ORPHAc's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 199.78
* Ranked among companies with meaningful Days Inventory only.

Orphazyme AS's Days Inventory stayed the same from Jun. 2021 (0.00) to Jun. 2022 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Orphazyme AS Days Inventory Historical Data

The historical data trend for Orphazyme AS's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Days Inventory Chart

Orphazyme AS Annual Data
Trend Jun14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Days Inventory
Get a 7-Day Free Trial - - - - -

Orphazyme AS Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Orphazyme AS's Days Inventory

For the Biotechnology subindustry, Orphazyme AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orphazyme AS's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Orphazyme AS's Days Inventory distribution charts can be found below:

* The bar in red indicates where Orphazyme AS's Days Inventory falls into.



Orphazyme AS Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Orphazyme AS's Days Inventory for the fiscal year that ended in Dec. 2021 is calculated as

Days Inventory (A: Dec. 2021 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2020 ) + Total Inventories (A: Dec. 2021 )) / count ) / Cost of Goods Sold (A: Dec. 2021 )*Days in Period
=( (0 + 0) / 1 ) / 0*365
=0 / 0*365
=N/A

Orphazyme AS's Days Inventory for the quarter that ended in Jun. 2022 is calculated as:

Days Inventory (Q: Jun. 2022 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Dec. 2021 ) + Total Inventories (Q: Jun. 2022 )) / count ) / Cost of Goods Sold (Q: Jun. 2022 )*Days in Period
=( (0 + 0) / 1 ) / 0*365 / 2
=0 / 0*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orphazyme AS  (CHIX:ORPHAc) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Orphazyme AS's Inventory Turnover for the six months ended in Jun. 2022 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Orphazyme AS's Inventory to Revenue for the six months ended in Jun. 2022 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Orphazyme AS Days Inventory Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Orphazyme AS Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS Headlines

No Headlines